近日,关于科兴生物的控制权争议出现新进展。由李嘉强担任董事长的科兴控股生物技术有限公司董事会,正全力推进既定优先事项。主要包括依照先前宣布的股息分配政策,向合法股东及其经纪商发放每股55美元特别现金股息(已于2025年7月支付);与纳斯达克合作推动恢复股票交易;任命新的审计机构;探索未来在港交所上市以提升流动性并实现价值最大化;以及制定未来公司长远的发展战略。据了解,现任董事会已于7月15日向...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.